About: MAPRx

A new report commissioned by the MAPRx Coalition examines the growing clinical evidence for coverage of anti-obesity medications (AOMs) approved by the Food and Drug Administration in Medicare Part D.

As the medical community’s understanding of disease states evolves, MAPRx is calling on the Part D program to evolve...

Earlier today, the MAPRx Coalition and 35 member organizations submitted a letter to Senate leadership ahead of their continued consideration of the Inflation Reduction Act of 2022 via the Senate's reconciliation process.

While members of the Coalition have differing views on other components of the expansive package, the Coalition and...

The Annual Open Enrollment for Medicare prescription drug coverage (Part D) is October 15, 2021 – December 7, 2021 for coverage beginning January 1, 2022. Plans make changes to benefits and costs, and there are also new plans in many areas of the country. Changes to the Part D benefit as a whole...

Earlier today, 29 members of the MAPRx Coalition sent a letter to Congressional leaders urging them to establish an out-of-pocket (OOP) cap for Medicare Part D to limit the amount Medicare beneficiaries have to pay for covered prescription drugs.

The Coalition continues to believe that the lack of an...

Earlier today, the MAPRx Coalition hosted a virtual briefing for members of Congress, their staff, and MAPRx member organizations.

After Corey Ford of Xcenda provided an overview of the Medicare Part D benefit, Illy Jaffer of the American Cancer Society Cancer Action Network and Bari Talente of the National...

Earlier today, the MAPRx Coalition and 27 of its member organizations submitted letters to House and Senate leadership in response to the ongoing congressional efforts to address drug pricing and affordability.

Specifically, the letters urged congressional leaders to focus on the...

Earlier today, the MAPRx Coalition and 38 health advocacy organizations sent a letter to Health and Human Services (HHS) Secretary Designee Xavier Becerra in opposition to recent proposed changes to Medicare Part D, including the longstanding six protected classes policy.

The changes, announced on January 19...

The Annual Open Enrollment for Medicare prescription drug coverage (Part D) is October 15, 2020 – December 7, 2020 for coverage beginning January 1, 2021. Plans make changes to benefits and costs, and there are also new plans in many areas of the country. Changes to the Part D benefit as a whole...

Earlier today, the MAPRx Coalition and 28 of its members, representing national patient, caregiver, and healthcare provider organizations, submitted comments to the Centers for Medicare and Medicaid Services (CMS) on their latest rule. Over the past 15 years, the Medicare Part D program has provided a critical avenue for beneficiaries to access prescription drugs. Its success...

Earlier today, the Medicare Access for Patients Rx Coalition (MAPRx) provided the Centers for Medicare & Medicaid Services (CMS) with our official commentary in response to the Advance Notice of Methodological Changes for Calendar Year 2021 for Medicare Advantage Capitation Rates and Part C and Part D Payment Policies – Part II released on February...